Skip to content

We are comparing two routes intamuscular and intravenous of carbetocin in pregnancy under going section

Comparative study of Injection Carbetocin Bolus versus Intravenous Carbetocin infusion on hemodynamic effects during lower segment Cesarean section under sub arachnoid block.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063758
Enrollment
100
Registered
2024-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: CARBETOCIN: Intravenous infusion over 15 minutes of dose 100mcg. Control Intervention1: Carbetocin: Intramuscular, bolus dose of 100mcg.

Sponsors

Sapthagiri Institute of Medical Science and Research Centre h
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Parturients undergoing lower segment cesarean section. American society of Anaesthesiologist grade 2

Exclusion criteria

Exclusion criteria: Parturients not giving consent, Preeclampsia,Gestational diabetes, previous pph,Abruptio placenta, placenta previous,other comorbidities

Design outcomes

Primary

MeasureTime frame
Hemodynamic effects after IV infusion or IM carbetocin given after delivery of fetus or placental delivery.Timepoint: 5MIN, 10MIN, 15MIN, 20MIN, 25MIN, 30 MIN

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactGirish M N

Sapthagiri Medical college and Hospital Research center

drgirishmn@gmail.com8790577591

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026